// App-Quantinova.ai

3522 : Circulating tumor DNA (ctDNA) utilizing a high-sensitivity panel to detect minimal residual disease post liver hepatectomy and predict disease recurrence.

Researchers

Presenter

  • Michael J. Overman

Principal Investigators

  • Jean-Nicolas Vauthey

  • Thomas A. Aloia

  • Claudius Conrad

  • Yun Shin Chun

  • Allan Andresson Lima Pereira

  • Zhiqin Jiang

  • Shadarra Crosby

  • Steven Wei

  • Kanwal Pratap Singh Raghav

  • Van Karlyle Morris

  • Michelle Tan

  • Annie Maslan

  • Amirali Talasaz

  • Stefanie Mortimer

  • Scott Kopetz

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, Brazil

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • 1.MD Anderson Cancer Center, Houston, TX

  • GI Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX

  • GUARDANT HEALTH, Inc., Redwood City, CA

  • Guardant Health, Rewdwood City, CA

Locations

  • United States

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved